Nadine Clemo

Nadine Clemo began their work experience as a Summer placement student at Syngenta in 2001. Nadine then joined GSK in 2007, where they held various roles including Senior Scientist, Scientific Investigator, and Project Coordinator for Cell & Gene Therapy Discovery Research. In 2016, Nadine joined Apollo Therapeutics LLP as a Drug Discovery Project Director, bringing their experience in preclinical biology roles at GSK. Currently, they serve as the Drug Discovery Program Director at Apollo Therapeutics.

Nadine Clemo completed a BSc in Biological Sciences from the University of Warwick from 1999 to 2002. After that, they pursued a PhD in Cancer Biology at the University of Bristol from 2003 to 2007.